Form 4: Spero Therapeutics Director Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Ankit Mahadevia, a director at Spero Therapeutics, sold 5,912 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
Summary
- On August 27, 2024, Ankit Mahadevia, a director of Spero Therapeutics, sold 5,912 shares of common stock.
- The sale was executed at a price of $1.35 per share.
- This transaction was conducted to cover tax withholding obligations associated with the vesting of RSUs granted to Mahadevia on August 26, 2021.
- Following the transaction, Mahadevia still beneficially owns 759,085 shares of Spero Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes on vested RSUs) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of RSUs are a common practice among company directors and officers. This transaction is a routine event and doesn't necessarily indicate a change in the director's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 08/26/2021 | Date RSUs were granted to Ankit Mahadevia |
| 08/27/2024 | Date of the stock sale transaction |
| 08/29/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.